Pinnacle Bancorp
REGN icon

Pinnacle Bancorp’s Regeneron Pharmaceuticals REGN Stock Holding History

Pinnacle Bancorp’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13.6K Sell
18
-4
-18% -$3.02K ﹤0.01% 686
2026
Q2 		$13.7K Buy
22
+4
+22% +$2.72K ﹤0.01% 695
2026
Q1 		$13.9K Hold
18
– – ﹤0.01% 657
2025
Q4 		$13.9K Hold
18
– – ﹤0.01% 643
2025
Q3 		$10.1K Buy
+18
New +$10.2K ﹤0.01% 730

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Vest Financial
Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
Atwood & Palmer
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Loring Wolcott & Coolidge Fiduciary Advisors
Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $10.8B AUM 9.05% 1-Year Est. Return
LMCG Investments
LMCG Investments Boston, Massachusetts $1.86B AUM 40.01% 1-Year Est. Return

Pinnacle Bancorp's REGN Position: Q3 2026 in Review

Pinnacle Bancorp reduced its Regeneron Pharmaceuticals (REGN) stake by 18% in Q3 2026, selling an estimated $3.02K and leaving 18 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #686.

Pinnacle Bancorp first reported a position in REGN in Q3 2025 and has held it in 5 quarters since. The position peaked at $13.9K in Q1 2026. 333 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Pinnacle Bancorp held 18 shares of Regeneron Pharmaceuticals worth $13.6K as of Q3 2026.
  • Pinnacle Bancorp sold 4 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $3.02K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Pinnacle Bancorp's portfolio in Q3 2026, its #686 holding.
  • Pinnacle Bancorp first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • Pinnacle Bancorp's Regeneron Pharmaceuticals position peaked at $13.9K in Q1 2026.
  • 333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Pinnacle Bancorp's 13F filing for Q3 2026, filed 21 Oct 2026.